Group 3 innate lymphoid cells (ILC3) are major regulators of inflammation and infection at mucosal barriers 1 . ILC3 development is thought to be programmed 1 , but how ILC3 perceive, integrate and respond to local environmental signals remains unclear. Here we show that ILC3 in mice sense their environment and control gut defence as part of a glial-ILC3-epithelial cell unit orchestrated by neurotrophic factors. We found that enteric ILC3 express the neuroregulatory receptor RET. ILC3-autonomous Ret ablation led to decreased innate interleukin-22 (IL-22), impaired epithelial reactivity, dysbiosis and increased susceptibility to bowel inflammation and infection. Neurotrophic factors directly controlled innate Il22 downstream of the p38 MAPK/ERK-AKT cascade and STAT3 activation. Notably, ILC3 were adjacent to neurotrophic-factor-expressing glial cells that exhibited stellateshaped projections into ILC3 aggregates. Glial cells sensed microenvironmental cues in a MYD88-dependent manner to control neurotrophic factors and innate IL-22. Accordingly, glial-intrinsic Myd88 deletion led to impaired production of ILC3-derived IL-22 and a pronounced propensity towards gut inflammation and infection. Our work sheds light on a novel multi-tissue defence unit, revealing that glial cells are central hubs of neuron and innate immune regulation by neurotrophic factor signals.
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increase of IL-22-producing ILC3, whereas their IL-17-producing counterparts were unaffected ( Fig.1h and Extended Data Fig. 2b ). To more specifically evaluate the effects of RET in ILC3, we deleted Ret in RORγ t-expressing cells by breeding Rorgt-Cre with Ret fl/fl mice 15, 16 (Extended Data Fig. 3a, b ). Analysis of Rorgt-CreRet fl/fl (Ret Δ ) mice revealed selective and extensive reduction of ILC3-derived IL-22, but normal IL-22-producing T cells ( Fig. 2a and Extended Data Fig. 3c, d ). IL-22 acts on epithelial cells to induce reactivity and repair genes 1 . When compared to their wild-type littermate controls, the Ret Δ epithelium revealed normal morphology, proliferation and paracellular permeability, but a marked reduction of epithelial reactivity and repair genes ( Fig. 2b and Extended Data Fig. 3e-h) . Accordingly, the Ret MEN2B epithelium displayed increased levels of these molecules in an IL-22-dependent manner ( Fig. 2b and Extended Data Fig. 3i ). These results indicate that RET signals selectively control innate IL-22 and shape intestinal epithelial reactivity.
To determine whether neurotrophic factors regulate intestinal defence, we tested how varying degrees of RET signals control enteric aggressions. Whereas Ret Δ mice treated with dextran sodium sulfate (DSS) had increased weight loss and inflammation, reduced IL-22producing ILC3, decreased epithelial reactivity/repair genes and pronounced bacterial translocation from the gut, Ret MEN2B mutants were highly protected compared to their wild-type littermate controls Fig. 4 ). As DSS largely causes epithelial injury, we tested whether ILC3-autonomous RET signals are required to control infection. To this end, Ret Δ mice were bred with Rag1 −/− mice to formally exclude adaptive T-cell effects. The resulting Rag1 −/− Ret Δ mice were infected with the attaching and effacing bacteria Citrobacter rodentium. When compared to their littermate controls, Rag1 −/− Ret Δ mice had marked gut inflammation, reduced IL-22-producing ILC3, increased C. rodentium infection and translocation, reduced epithelial reactivity genes, increased weight loss and reduced survival ( Fig. 2k -n and Extended Data Fig. 5 ). Altogether, these data indicate that ILC3-intrinsic neurotrophic factor cues regulate gut defence and homeostasis.
We used a multi-tissue organoid system to show that IL-22 is the molecular link between RET-dependent ILC3 activation and epithelial reactivity. Addition of GFL to ILC3-epithelial organoids strongly induced epithelial reactivity genes in an IL-22-and RET-dependent manner (Fig. 3a, b and Extended Data Fig. 6a ). To further examine how RET signals control innate IL-22, we investigated a gene signature LETTER RESEARCH associated with ILC identity 1 . Whereas the master ILC transcription factors Runx1, Id2, Gata3, Rora, Rorgt, Ahr and Stat3 were unperturbed, Il22 was significantly reduced in Ret Δ ILC3 ( Fig. 3c and Extended Data Fig. 6b ). Accordingly, activation of ILC3 with all or distinct GFL-GFRα pairs in trans efficiently increased Il22 despite normal expression of other ILC3-related genes ( Fig. 3d and Extended Data Fig. 6c ). Activation of RET by GFL leads to p38 MAPK/ERK-AKT cascade activation in neurons, whereas phosphorylation of STAT3 shapes Il22 expression 7, 17 . Analysis of Ret Δ ILC3 revealed hypo-phosphorylated ERK1/2, AKT, p38/MAP kinase and STAT3 ( Fig. 3e and Extended Data Fig. 6d ). Accordingly, GFL-induced RET activation in ILC3 led to rapid ERK1/2, AKT, p38/MAP kinase and STAT3 phosphorylation and increased Il22 transcription (Fig. 3d, f and Extended Data Fig. 6e, f) . Accordingly, inhibition of ERK, AKT or p38/MAP kinase upon GFL activation led to impaired STAT3 activation and Il22 expression ( Fig. 3g, h) . Finally, inhibition of STAT3 upon GFL-induced RET activation led to decreased Il22 (Fig. 3h ). To examine whether GFL directly regulate Il22, we performed chromatin immunoprecipitation (ChIP) 18 (Fig. 3i, j) . Stimulation of ILC3 with GFL resulted in increased binding of pSTAT3 in the Il22 promoter and increased trimethyl-H3K36 at the 3' end of Il22, indicating active Il22-transcribed regions 19 (Fig. 3d, j) . Thus, cell-autonomous RET signals control ILC3 function and gut defence by direct regulation of Il22 downstream of STAT3 activation.
Propensity towards inflammation and dysregulation of intestinal homeostasis have been associated with dysbiosis 20, 21 . When compared to their wild-type littermates, Ret Δ mice have altered microbial communities as evidenced by quantitative analysis, weighted UniFrac analysis and significantly altered levels of Sutterella, unclassified Clostridiales and Bacteroides (Fig. 4a and Extended Data Fig. 7 ). Discrete microbial communities may have transmissible colitogenic potential 20, 21 . Nevertheless, germ-free mice colonized with the microbiota of Ret Δ or their control littermates revealed similar susceptibility to DSS-induced colitis and identical innate IL-22 production ( Fig. 4b-d ).
In agreement, co-housed Ret Δ and wild-type littermates had different propensity towards intestinal inflammation (Fig. 2c, d) . Together, these data indicate that dysbiosis per se is insufficient to cause altered innate IL-22 and susceptibility to gut inflammation as observed in Ret Δ mice ( Fig. 2c-f ). Thus, we hypothesised that GFL-producing cells integrate commensal and environmental signals to control innate IL-22. Accordingly, antibiotic treatment of Ret Δ and their wild-type littermate controls resulted in similar ILC3-derived IL-22 (ref. 22) ( Fig. 4e ).
Neurotrophic factors of the GDNF family were shown to be produced by enteric glial cells, which are neuron-satellites expressing the glial fibrillary acidic protein (GFAP) 7, 23 . Notably, double reporter mice for ILC3 (Ret GFP ) and glial cells (Gfap-CreRosa26 RFP ) revealed that stellate-shaped projections of glial cells are adjacent (4.35 ± 1.42 μ m) to RORγ t + ILC3 within cryptopatches ( Fig. 4f and Extended Data Fig. 8a) . These data suggest the existence of paracrine glial-ILC3 crosstalk orchestrated by neurotrophic factors. Accordingly, lamina propria glial cells were the main producers of GFL (Extended Data Fig. 8b ). Recent studies have shown that glial cells express pattern recognition receptors, notably Toll-like receptors (TLRs) 24, 25 . Activation of neurosphere-derived glial cells revealed they specifically respond to TLR2, TLR4, and the alarmins IL-1β and IL-33, which efficiently controlled GFL expression and induced robust innate Il22 in a MYD88dependent manner (Fig. 4g-i and Extended Data Fig. 8c-g) . To formally demonstrate the physiological importance of MYD88-dependent glial cell sensing on innate IL-22 production, we deleted Myd88 in GFAPexpressing glial cells by breeding Gfap-Cre with Myd88 fl/fl mice 26, 27 . Remarkably, glial-intrinsic deletion of Myd88 resulted in decreased intestinal GFL, increased gut inflammation, impaired ILC3-derived IL-22, and increased weight loss ( Fig. 4j-m ; Extended Data Fig. 9a-d) .
In agreement, Gfap-CreMyd88 Δ mice had increased susceptible to C. rodentium infection (Extended Data Fig. 9e-h) . Thus, mucosal glial cells orchestrate innate IL-22 via neurotrophic factors, downstream of MYD88-dependent sensing of commensal products and alarmins.
Defining the mechanisms by which ILC3 integrate environmental cues is critical to understanding mucosal homeostasis. Our work sheds light on the relationships between ILC3 and their microenvironment, notably through decoding a novel glial-ILC3-epithelial cell unit orchestrated by neurotrophic factors (Extended Data Fig. 10 ). Glial-derived neurotrophic factors operate in an ILC3-intrinsic manner by activating the tyrosine kinase RET, which directly regulates innate IL-22 downstream of p38 MAPK/ERK-AKT and STAT3 phosphorylation (Extended Data Fig. 10) . Future studies will further elucidate the mechanisms inducing RET expression in ILC3.
Our data demonstrate that, in addition to their well-established capacity to integrate dendritic-cell-derived cytokines 1 , ILC3 perceive distinct multi-tissue regulatory signals leading to STAT3 activity and IL-22 expression, notably by integration of glial-cell-derived neuroregulators. Thus, rather than providing hard-wired signals for 
ILC3-immunity, we propose that RET signalling induces fine-tuned innate IL-22 production that leads to efficient gut homeostasis and defence.
Previous studies demonstrated that neurons may indirectly shape fetal lymphoid tissue inducer cell aggregation via regulation of mesenchymal cells and that ablation of glial cells leads to gut inflammation 28, 29 ; here we reveal that glial cells are central hubs of neuronal and innate immune regulation. Notably, neurotrophic factors are the molecular link between glial cell sensing, innate IL-22 and intestinal epithelial defence. Thus, it is tempting to speculate that glial-immune cell units might be also critical to the homeostasis of other barriers, notably in the skin, lung and brain 30 . From an evolutionary perspective, coordination of innate immunity and neuronal function may ensure efficient mucosal homeostasis and a co-regulated neuro-immune response to various environmental challenges, including xenobiotics, intestinal infection, dietary aggressions and cancer. (ref. 27) were in F8-F9 to a C57Bl/6J background. All lines were bred and maintained at IMM Lisboa animal facility. Mice were systematically compared with co-housed littermate controls. Both males and females were used in this study. Randomization and blinding were not used unless stated otherwise. All animal experiments were approved by national and institutional ethical committees, respectively, Direção Geral de Veterinária and iMM Lisboa ethical committee. Germ-free mice were housed at Instituto Gulbenkian de Ciência, Portugal, and Institut Pasteur, France, in accordance to institutional guidelines for animal care. Power analysis was performed to estimate the number of experimental mice. Generation of fetal liver chimeras. For reconstitution experiments, 5 × 10 6 fetal liver cells were isolated from E14.5 Ret WT/GFP or Ret GFP/GFP mice and injected intravenously into non-lethally irradiated (200 rad) alymphoid Rag1 −/− γ c −/− hosts. Mice were analysed 8 weeks after transplantation. DSS-induced colitis. Dextran sodium sulfate (DSS) (molecular mass 36,000-50,000 Da; MP Biomedicals) was added into drinking water 3% (w/v) for 5 days followed by 2 days of regular water. Mice were analysed at day 7. Body weight, presence of blood and stool consistency was assessed daily. Citrobacter rodentium infection. Infection with Citrobacter rodentium ICC180 (derived from DBS100 strain) 37 was performed by gavage inoculation of 10 9 colony-forming units 37, 38 . Acquisition and quantification of luciferase signal was performed in an IVIS system (Caliper Life Sciences). Throughout infection, weight loss, diarrhoea and bloody stools were monitored daily. Antibiotic treatment. Pregnant females or newborn mice were treated with streptomycin 5 g l −1 , ampicillin 1 g l −1 and colistin 1 g l −1 (Sigma-Aldrich) into drinking water with 3% sucrose. Control mice were given 3% sucrose in drinking water as previously described 22 . Microscopy. Intestines from Ret GFP and Ret GFP chimaeras were imaged in a Zeiss Lumar V12 fluorescence stereo microscope with a NeoLumar S 0.8× objective using the GFP filter. Whole-mount analysis was performed as previously described 2, 9 . Briefly, adult intestines were flushed with cold PBS (Gibco) and opened longitudinally. Mucus and epithelium was removed and intestines were fixed in 4% PFA (Sigma-Aldrich) at room temperature for 10 mins and incubated in blocking/permeabilizing buffer solution (PBS containing 2% BSA, 2% goat serum, 0.6% Triton X-100). To visualise three-dimensional structures of the small intestine, samples were cleared with benzyl alcohol-benzyl benzoate (Sigma-Aldrich) before dehydration in methanol 2, 9 . For analysis of thick gut sections, intestines were fixed with 4% PFA at 4 °C overnight and were then included in 4% low-melting temperature agarose (Invitrogen). Sections of 100 μ m were obtained with a Leica VT1200/VT1200 S vibratome and embedded in Mowiol (Calbiochem) 2 . Slides or whole-mount samples were incubated overnight or for 1-2 days respectively at 4 °C using the following antibodies: rat monoclonal anti-B220 (RA3-6B2) (eBioscience), mouse monoclonal anti-RORγt (Q31-378) (BD Pharmigen), mouse monoclonal anti-GFAP (GA-5) (Sigma-Aldrich), mouse monoclonal anti-GFAP Cy3 (GA-5) (Abcam), anti-GDNF antibody (Abcam), DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) (Invitrogen). A647 goat anti-rat, A568 goat anti-rat, A647 goat anti-mouse, A488 rabbit anti-GFP, and A488 goat anti-rabbit secondary antibodies were purchased from Invitrogen. Neurospheres and cultured glial cells were fixed in PFA 4% for 10 minutes at room temperature and permeabilized in PBS-Triton 0.1% within 30 seconds. After several washing steps with PBS, cells were incubated with antibodies for 3 h at room temperature and then mounted in Mowiol 39 . Samples were acquired on a Zeiss LSM710 confocal microscope using EC Plan-Neofluar 10× /0.30 M27, Plan Apochromat 20× /0.8 M27 and EC Plan-Neofluar 40× /1.30 objectives. Three-dimensional reconstruction of images was achieved using Imaris software and snapshot pictures were obtained from the three-dimensional images. For analysis of confocal images, cells were counted using in-house software, written in MATLAB (Mathworks, Natick, MA). Briefly, single-cell ILC3 nuclei were identified by RORγ t by thresholding and particle analysis. Regions of interest (ROIs) (Extended Data Fig.1i ; bottom panels) were defined from each nucleus for analysis in the GFP channel, where staining was considered positive if a minimum number of pixels (usually 20) were above a given threshold. The software allows for batch processing of multiple images and generates individual report images for user verification of cell-counting results and co-expression analysis (https:// imm.medicina.ulisboa.pt/en/servicos-e-recursos/technical-facilities/bioimaging). Histopathology analysis. Colon samples were fixed in 10% neutral buffered formalin. The colon was prepared in multiple cross-sections or 'swiss roll' technique 40 , routine-processed for paraffin embedding and 3-4μ m sections were stained with haematoxylin and eosin. Enteric lesions were scored by a pathologist blinded to experimental groups, according to previously published criteria [41] [42] [43] . Briefly, lesions were individually scored (0-4 increasing severity) for the following criteria: 1, mucosal loss; 2, mucosal epithelial hyperplasia; 3, degree of inflammation; 4, extent of the section affected in any manner; and 5, extent of the section affected in the most severe manner as previously described 43 . Final scores were derived by summing the individual lesion and the extent scores. The internal diameter of the crypts was measured in at least five fields (10× magnification), corresponding to the hotspots in which the most severe changes in crypt architecture were seen. Measurements were performed in an average of 35 crypts per mouse, from proximal to distal colon. Intestinal villus height was measured in the jejunum. Measurements were performed in slides scanned using a Hamamatsu Nanozoomer SQ digital slide scanner running NDP Scan software. Enteric glial cell isolation. Enteric glial cells isolation was adapted from previously described protocols 44, 45 . Briefly, the muscularis layer was separated from the submucosa with surgical forceps under a dissection microscope (SteREO Lumar. V12, Zeiss). The lamina propria was scraped mechanically from the underlying submucosa using 1.5-mm cover-slips (Thermo Scientific). Isolated tissues were collected and digested with Liberase TM (7,5 μ g ml −1 ; Roche) and DNase I (0.1 mg ml −1 ; Roche) in RPMI supplemented with 1% HEPES, sodium pyruvate, glutamine, streptomycin and penicillin and 0.1% β -mercaptoethanol (Gibco) for approximately 40 min at 37 °C. Single-cell suspensions were passed through a 100-μ m cell strainer (BD Biosciences) to eliminate clumps and debris. Flow cytometry and cell sorting. Lamina propria cells were isolated as previously described 46 . Briefly, intestines were digested with collagenase D (0.5 mg ml −1 ; Roche) and DNase I (0.1 mg ml −1 ; Roche) in RPMI supplemented with 10% FBS, 1% HEPES, sodium pyruvate, glutamine, streptomycin and penicillin and 0.1% β -mercaptoethanol (Gibco) for approximately 30 min at 37 °C under gentle agitation. For cytokine analysis, cell suspensions were incubated 4 h in PMA/ ionomycin (Sigma-Aldrich) and brefeldin A (eBioscience) at 37 °C. Intracellular staining was performed using IC fixation/permeabilization kit (eBioscience). Cells were stained using PBS, 1% FBS, 1% HEPES and 0.6% EDTA (Gibco). Flow cytometry analysis and cell sorting was performed using FORTESSA and FACSAria flow cytometers (BD Biosciences). Data analysis was performed using FlowJo software (Tristar). Sorted populations were > 95% pure. Cell suspensions were stained with anti-CD45 (30-F11), anti-TER119 (TER-119), TCRβ (H57-597), anti-CD3ε (eBio500A2), anti-CD19 (eBio1D3), anti-NK1.1 (PK136), anti-CD11c (N418), anti-Gr1 (RB6-8C5), anti-CD11b (Mi/70), anti-CCR6 (29-2L17), anti-CD127 (IL-7Rα ; A7R34), anti-Thy1.2 (53-2.1), anti-CD49b (DX5), anti-TCRδ (GL3), anti-NKp46 (29A1.4), anti-IL-17 (eBio17B7), anti-IL-22 (1H8PWSR), rat IgG1 isotype control (eBRG1) antibodies, 7AAD viability dye, anti-mouse CD16/ CD32 (Fc block), anti-RORγ t (AFKJS-9); rat IgG2a κ isotype control (eBR2a) and streptavidin fluorochrome conjugates all from eBioscience; anti-CD4 (GK1.5), anti-CD31 (390), anti-CD8α (53-6.7), anti-CD24 (M1/69), anti-Epcam (G8.8) antibodies were purchased from Biolegend. Anti-RET (IC718A) antibody was purchased from R&D Systems. LIVE/DEAD Fixable Aqua Dead Cell Stain Kit was purchased from Invitrogen. Cell populations were defined as: ILC3 -CD45 + Lin − Thy1.2 hi IL7Rα + RORγ t + . For ILC3 subsets, additional markers were employed: LTi -CCR6 + Nkp46 − ; ILC3 NCR − -CCR6 − Nkp46 − ; ILC3 NCR + -CCR6 − Nkp46 + . Lineage was composed from CD3ε, CD8α , TCRβ , TCRγ δ , CD19, Gr1, CD11c and TER119. Glial cells -CD45 − CD31 − TER119 − CD49b + (ref. 47); T cells -CD45 + CD3ε + ; γ δ T cells -CD45 + CD3ε + γ δ TCR + ; B cells -CD45 + CD19 + B220 + ; macrophages -CD45 + CD11b + F4/80 + ; dendritic cells -CD45 + CD19 − CD3ε − MHCII + CD11c + ; enteric neurons -CD45 − RET/GFP + (ref. 13); epithelial cells -CD45 − CD24 + Epcam + . Quantitative RT-PCR. Total RNA was extracted using RNeasy micro kit (Qiagen) or Trizol (Invitrogen) according to the manufacturer's protocol. RNA concentration was determined using Nanodrop Spectrophotometer (Nanodrop Technologies). Quantitative real-time reverse transcription (RT)-PCR was performed as previously described 2, 8, 9 . Hprt and Gapdh were used as housekeeping genes. For TaqMan assays (Applied Biosystems), RNA was retro-transcribed using a High Capacity RNA-to-cDNA Kit (Applied Biosystems), followed by a pre-amplification PCR using TaqMan PreAmp Master Mix (Applied Biosystems). TaqMan Gene Expression Master Mix (Applied Biosystems) was used in real-time PCR. TaqMan Gene Expression Assays (Applied Biosystems) were the following: Gapdh Mm99999915_g1; Hprt Mm00446968_m1; Artn Mm00507845_m1; Nrtn Mm03024002_m1; Gdnf Mm00599849_m1; Gfra1 Mm00439086_m1; Gfra2 Mm00433584_m1; Gfra3 Mm00494589_m1; Ret Mm00436304_m1; Il22 Mm01226722_g1; Il17a Mm00439618_m1; Il23r Mm00519943_m1; Rorgt Mm01261022_m1; Il7ra Mm00434295_m1; Ahr Mm00478932_m1; Stat3 Mm01219775_m1; Cxcr6 Mm02620517_s1; Nfkbiz Mm_00600522_m1; Reg3a Mm01181787_m1; Reg3b Mm00440616_g1; Reg3g Mm00441127_m1;
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